Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Imperialine is a **steroidal alkaloid** found primarily in the bulbs of plants in the Fritillaria genus, such as Fritillaria cirrhosa, Fritillaria imperialis, and Petilium eduardi. It is one of the major bioactive constituents of the traditional Chinese medicine chuanbeimu (Bulbus Fritillariae Cirrhosae), which has been widely used as an **antitussive and expectorant** in respiratory conditions such as cough, asthma, and other pulmonary diseases[1][3][6]. Imperialine possesses a cevan-type steroidal backbone, exhibits moderate alkalinity (pKa ≈ 8.5), and displays pharmacological effects including **mitigation of pulmonary impairment and suppression of inflammatory cytokines** (e.g., IL-1β, IL-6, IL-8, TNF-α) in COPD-like rat models[1]. The key mechanism appears to involve **passive membrane diffusion** across the intestinal wall, without evidence of active transporter involvement[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on imperialine.